ELCA
Coronary laser atherectomy catheter
  • ELCA coronary laser atherectomy catheter producing a vapor bubble in soft gel
  • Optimally spaced fibers for improved performance.  Adjustable laser energy settings to satisfy many clinical needs.
  • Standard Product Photograph

ELCA

Coronary laser atherectomy catheter
ELCA coronary laser atherectomy catheters are designed to cross, prepare and treat the most complex coronary lesions. This non-mechanical atherectomy catheter can be delivered over any .014” wire and can de-bulk and modify plaque of multiple morphologies and is approved for the broadest range of coronary indications in atherectomy.

Clinical image gallery

  • Modifies plaque even behind stent struts
    Modifies plaque even behind stent struts
  • Adjustable laser energy settings to satisfy many clinical needs
    Adjustable laser energy settings to satisfy many clinical needs
Features
Optimal vessel preparation
Can be used with any coronary .014” wire and multiple wires in place.
Optimal vessel preparation
Two-thirds vessel sizing rule
Two-thirds vessel sizing rule for predictable outcomes.
Two-thirds vessel sizing rule
Automatic shut-off feature
Automatic shut-off feature for advanced patient safety.


Specifications
  • 0.9mm X-80
    Model number
    110-004
    Guidewire compatibility
    0.014 in
    Guide catheter compatibility
    6 F
    Minimum vessel diameter
    2.0 mm
    Max tip outer diameter
    0.038 in
    Max shaft outer diameter
    0.049 in
    Working length
    130 cm
    Fluence
    30-80 mJ / mm²
    Repetition rate
    25-80 Hz
    Laser on / off time
    10 / 5 sec
  • 1.4mm
    Model number
    114-009
    Guidewire compatibility
    0.014 in
    Guide catheter compatibility
    6 / 7 F
    Minimum vessel diameter
    2.2 mm
    Max tip outer diameter
    0.057 in
    Max shaft outer diameter
    0.062 in
    Working length
    130 cm
    Fluence
    30-60 mJ / mm²
    Repetition rate
    25-40 Hz
    Laser on / off time
    5 / 10 sec
  • 1.7mm
    Model number
    117-016
    Guidewire compatibility
    0.014 in
    Guide catheter compatibility
    7 F
    Minimum vessel diameter
    2.5 mm
    Max tip outer diameter
    0.069 in
    Max shaft outer diameter
    0.072 in
    Working length
    130 cm
    Fluence
    30-60 mJ / mm²
    Repetition rate
    25-40 Hz
    Laser on / off time
    5 / 10 sec
  • 2.0mm
    Model number
    120-009
    Guidewire compatibility
    0.014 in
    Guide catheter compatibility
    8 F
    Minimum vessel diameter
    3 mm
    Max tip outer diameter
    0.080 in
    Max shaft outer diameter
    0.084 in
    Working length
    130 cm
    Fluence
    30-60 mJ / mm²
    Repetition rate
    25-40 Hz
    Laser on / off time
    5 / 10 sec


Documentation

Product brochure
PDF|3.18 MB

Related products

  • CVX-300 Excimer laser system
    The only PMA approved excimer laser system and disposable catheters for the treatment of coronary arterial disease. CVX-300 is also indicated for use in the treatment of peripheral arterial disease. Photoablation is the use of light to break down, vaporize and remove matter. The CVX-300 excimer laser system facilitates photoablation via a variety of Philips laser catheters to remove binding arterial plaques.
  • Philips Laser System — Nexcimer Laser system for coronary and peripheral atherectomy and lead management
    Philips Laser System —Nexcimer— photoablates a wide spectrum of morphologies. Philips laser catheters are indicated in many vessel types and is the only laser system available for lead removal. Powered by a common 100-240V electrical outlet, the system warms up in less than 30 seconds for an easy and fast set-up.
Disclaimer
1. Tcheng, J.E. et al. (1995). Development of a New Technique for Reducing Pressure Pulse Generation During 308-nm Excimer Laser Coronary Angioplasty. Catheterization and Cardiovascular Diagnosis. 34, 15-22.
2. Topaz, On, et al, 2001. Optimal Spaced Excimer Laser Coronary Catheters Performance Analysis, Journal of Clinical Laser Medicine and Surgery, Vol 19, Issue 1, 9-14.
ELCA important safety information
Indications: The laser catheters are intended for use either as a stand-alone modality or in conjunction with percutaneous transluminal coronary balloon angioplasty (PTCA) in patients who are acceptable candidates for coronary artery bypass graft (CABG) surgery. The following indications for use, contraindications and warnings have been established through multicenter clinical trials. The Philips CVX-300 Excimer laser system and the multi-fiber laser catheter models are safe and effective for the following indications: occluded saphenous vein bypass grafts, ostial lesions, long lesions (greater than 20mm in length), moderately calcified stenosis, total occlusions traversable by a guidewire, lesions which previously failed balloon angioplasty, restenosis in 316L stainless steel stents, prior to the administration of intravascular brachytherapy. These lesions must be traversable by a guidewire and composed of atherosclerotic plaque and/or calcified material. The lesions should be well defined by angiography.
Contraindications: Lesion is in an unprotected left main artery. Lesion is beyond acute bends or is in a location within the coronary anatomy where the catheter cannot traverse. Guidewire cannot be passed through the lesion. Lesion is located within a bifurcation. Patient is not an acceptable candidate for bypass graft surgery.
Potential adverse events: Use of the Philips CVX-300 Excimer laser system may contribute to the following complications: dissection of the arterial wall, perforation, acute reclosure, embolization, aneurysm formation, spasm, coronary artery bypass graft surgery, thrombus, myocardial infarction, arrhythmia, filling defects, death. No long term adverse effects of ELCA are known at this time.
Risks: The primary endpoint defined in the laser angioplasty of restenosis stents (LARS) randomized trial was the absence of major adverse cardiac events (MACE) at 6 months: Death; myocardial infarction; coronary artery bypass surgery. Procedural complications include: any dissection, acute thrombus, haziness, no reflow, arrhythmia, acute vessel closure, occlusion of side branch, occlusion non-target, coronary spasm, coronary embolism, coronary perforation, laser/stent damage, balloon/stent damage, and other serious.
Caution: Federal law restricts this device to sale by or on the order of a physician.
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.
ELCA is distributed by LifeSystems in Australia and New Zealand.
Always read the label and follow the directions for use.
Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.
Philips reserves the right to change product specifications without prior notification.
©2025 Koniklijke Philips N.V. All rights reserved. Trademarks are the property of Koninklijke Philips N.V. or their respective owners.